Pharmacodynamics, pharmacokinetics and biodistribution of recombinant human N-acetylgalactosamine 4-sulfatase after 6months of therapy in cats using different IV infusion durations

Molecular Genetics and Metabolism
Therese RuaneCharles A O'Neill

Abstract

Mucopolysaccharidosis VI (MPS VI) is a lysosomal storage disease characterized by an absence or marked reduction of lysosomal N-acetylgalactosamine-4-sulfatase activity. Affected individuals have widespread accumulation of unmetabolized glycosaminoglycan substrates leading to detrimental effects. Recombinant human N-acetylgalactosamine 4-sulfatase (rhASB) is an approved enzyme replacement therapy for patients with MPS VI. Despite the known efficacy of weekly 4-h rhASB infusions, some clinicians wish to treat patients using reduced infusion times. This study compared the pharmacodynamics, pharmacokinetics, and tissue biodistribution of rhASB when administered as 2- and 4-h intravenous infusions using a feline model of MPS VI. Study animals were MPS VI-affected cats that demonstrate clinical signs and biochemical derangements similar to human MPS VI patients. Beginning at age 4weeks, animals received weekly 2-h (N=6) or 4-h (N=6) IV infusions of rhASB for 26weeks (Naglazyme® [galsulfase] Solution for Intravenous Infusion; BioMarin Pharmaceutical, Inc.). The control group consisted of untreated MPS VI-affected cats (N=6). The pharmacokinetic parameters of plasma rhASB and urinary glycosaminoglycan were determined at weeks 13 and 2...Continue Reading

References

Apr 15, 1996·The Journal of Clinical Investigation·A C CrawleyJ J Hopwood
Feb 15, 2001·The New England Journal of Medicine·E D KakkisE F Neufeld
Aug 3, 2007·Pediatrics·Roberto GiuglianiJames E Wraith
May 30, 2008·Journal of Inherited Metabolic Disease·M M SleeperM E Haskins
Apr 14, 2010·Orphanet Journal of Rare Diseases·Vassili ValayannopoulosSean Turbeville
Jun 4, 2011·Genetics and Molecular Biology·Roberto GiuglianiAna Maria Martins
Oct 11, 2013·Journal of Inherited Metabolic Disease·Paul R HarmatzCeleste Decker

❮ Previous
Next ❯

Citations

May 5, 2016·Annals of the New York Academy of Sciences·Miao XuElizabeth A Ottinger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.